share_log

BioCryst Pharmaceuticals | 8-K: BioCryst Reports First Quarter 2023 Financial Results and Provides Business Update

SEC announcement ·  May 3, 2023 07:08
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more